# Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. – FDA Inspection, Jul 29, 2016

Source: https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/97923d47-e3d6-4e95-ab1f-fb4ed076a382
Source feed: FDA_Inspections

> FDA inspection 990181 of Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd., July 29, 2016. Classification: Voluntary Action Indicated (VAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 990181
- Company Name: Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- Inspection Date: 2016-07-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1265022 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/9173306d-cce2-4074-a429-0c5f2e571d00)
- FDA Inspection 1107819 - 2019-09-13
- FDA Inspection 1070378 - 2018-10-18
- FDA Inspection 1053977 - 2018-05-11
- FDA Inspection 879374 - 2014-04-25

Company: https://www.keypedia.com/companies/hangzhou-minsheng-binjiang-pharmaceutical-co-ltd/60558281-5fe9-47ef-a772-a976c821d6b2

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c